NowPatient logo

NowPatient Review

6.9
★★★★☆3.5/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10

Best for: Brand-name GLP-1 access without a compounded route

NowPatient scores highest on the strength of its clinical program: drug options and dosing support.

What the plan covers

Medication

Included

Provider visits

Included

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

NowPatient is a US-UK telehealth platform that prescribes brand-name weight-loss medicines only: Mounjaro, Wegovy (injection and tablet), Saxenda and Foundayo. The consultation is free and you pay for the medication. Prices are listed per pack, not per month, and rise with strength: the lowest-strength packs start at $99 for 30 Wegovy tablets, $113.85 for 30 Foundayo tablets, $215.98 for a Wegovy pen and $251.98 for a Mounjaro pen, plus a shipping and import duties charge.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
BrandFree Consultation

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to NowPatient

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
NowPatient logo
3.5 / 5
Our editorial rating
Visit NowPatient →

from $99 total · no insurance needed

NowPatient at a glance

Type
GLP-1 telehealth provider
Starting price
$99 total
What's included
Medication · Consult
FDA status
No FDA warning letter on record

How we scored NowPatient

Each dimension is scored algorithmically from NowPatient’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.2/10

NowPatient does not post a standard monthly cash price up front, so cost transparency is limited. Confirm the ongoing rate before you commit.

Effectiveness25%

8.3/10

NowPatient offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions.

User Experience15%

7.0/10

Online intake and platform experience (consult included in the price); 2 platform features disclosed.

Trust & Safety15%

7.2/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.0/10

NowPatient's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

5.8/10

NowPatient provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this NowPatient review

Last checked November 2026
  • Confirmed current pricing across 5 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$99–$441/mo across 5 dose/plan tiers (checked November 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with NowPatient

We walked NowPatient’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Search for the treatment/condition.
  2. 2Complete a health profile.
  3. 3Book a consultation (slots up to 7 days ahead).
  4. 4Attend a video consultation with a clinician.
  5. 5Receive the treatment if prescribed (delivered by post).
Price shown before you startLive video visit required
  • GLP-1 meds listed: Mounjaro, Wegovy injection & tablets, Saxenda (UK brand names for a UK-centric service).
  • Each treatment page shows the price of the default pack, a shipping and import duties line and a 'Total if approved' figure before you start; the consultation itself is free.
  • Blood-pressure readings are required for certain medications via a cuffless smartphone-camera method (not lab bloodwork).
  • A video consultation is explicitly part of the flow.

NowPatient customer support

Hours
Mon-Fri 8am-5pm EST (US); Mon-Fri 9am-6pm GMT (UK)

GLP-1 medications NowPatient offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Mounjaro (brand, cash-pay): per pack, 2.5mg/0.5mL KwikPen × 1Brand-name
$251.98total
tirzepatide

Lowest strength, smallest pack. The treatment page adds $75.00 for shipping and import duties.

Wegovy injection (brand, cash-pay): per pack, 0.25mg prefilled pen × 1Brand-name
$215.98total
semaglutide

Lowest strength, smallest pack. The treatment page adds $75.00 for shipping and import duties.

Wegovy oral tablet (brand, cash-pay): per pack of 30 tablets at 1.5mgBrand-name
$99total
semaglutide

30 tablets at the lowest strength. The treatment page adds $20.00 for shipping and import duties.

Saxenda (brand, cash-pay): per pack, 6mg/mL × 5Brand-name
$440.82total
liraglutide

Smallest pack. The treatment page adds $75.00 for shipping and import duties.

Foundayo (brand, cash-pay): per pack of 30 tablets at 0.8mgBrand-name
$113.85total
orforglipron

30 tablets at the lowest strength. The treatment page adds $20.00 for shipping and import duties.

Ready to get started?

Plans and promotions change often, so check NowPatient's current pricing and active discounts before you decide.

See NowPatient pricing →

What we like

  • Free telehealth consultation; you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection and tablets, Saxenda and Foundayo all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options: every drug is FDA-approved brand-name

Watch-outs

  • Prices are per pack and rise with strength, and each order adds a shipping and import duties charge
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront

NowPatient: an all-brand GLP-1 route with a free consult and no premium on the drug

NowPatient is unusual in a market that runs on compounded copies. It's a US-UK telehealth platform, headquartered in Austin, that prescribes only FDA-approved brand-name weight-management medicines: Mounjaro, Wegovy as both an injection and an oral tablet, Saxenda and Foundayo. The pitch is simple and open about its own economics: the consultation is free, and you pay only for the cost of the medication itself. If you specifically want the branded drug and not a pharmacy-compounded version, NowPatient is built for you. If you came here hunting for the cheapest possible monthly price, this is almost certainly not your provider.

How the pricing works: free visit, brand list price for the drug

There is no membership, no program fee, and no consult charge. NowPatient's own FAQ states it plainly: 'the consultation itself is completely free,' and if a clinician prescribes medication, 'you only pay for the cost of the medication' and nothing else. The medication is the full branded product, though, so your out-of-pocket effectively tracks each manufacturer's cash list price. The pricing basis is the thing most likely to mislead you here: every figure NowPatient publishes is the price of a pack, and the site never puts the word 'month' beside any of them. The entry price is $251.98 for a Mounjaro pack at the lowest strength, $215.98 for a Wegovy injection pack, and $440.82 for Saxenda. Each of those is the smallest pack at the lowest dose. They are floors, not what a maintenance dose will cost you. The low figures are for tablets: $99 buys 30 Wegovy tablets at 1.5mg and $113.85 buys 30 Foundayo tablets at 0.8mg, each a month's worth of pills only if your dose stays at the bottom of the ladder. Every order also carries a shipping and import duties line, $75 on pens and $20 on tablets, which the treatment page adds into a "Total if approved" figure.

To put that in perspective, the category median monthly price is about $179, a figure built largely on compounded semaglutide and tirzepatide. NowPatient sits many multiples above that line because brand-name GLP-1s cost what they cost when you pay cash, not because it marks the drug up. You're trading price for the brand.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

The medication catalog, including the rare oral Wegovy option

NowPatient's weight-management lineup covers four molecules: tirzepatide as Mounjaro, semaglutide as Wegovy, liraglutide as Saxenda, and orforglipron as Foundayo. Wegovy comes in both the familiar weekly injection and the newer oral tablet, and NowPatient is one of the few places you'll find the pill version at all. With Foundayo as a second daily pill, people who dread needles have a concrete reason to look here rather than at a compounding-only clinic.

  • Mounjaro (tirzepatide injection): the weekly pen, from $251.98 at the lowest strength
  • Wegovy injection (semaglutide): the standard weekly pen, from $215.98
  • Wegovy oral tablet (semaglutide): the needle-free pill, rarely offered elsewhere, from $99 for 30 tablets
  • Foundayo (orforglipron tablet): a daily pill with no fasting rule, from $113.85 for 30 tablets
  • Saxenda (liraglutide injection): an older daily-injection option, from $440.82 for five pens

Brand-only, with no premium on the drug

NowPatient is all-brand by design, with no compounded semaglutide or tirzepatide anywhere in the catalog. Every drug you can get is the FDA-approved product straight from the manufacturer, which removes the formulation-quality and sourcing questions that hang over the compounded market. It also doesn't pad the bill: no premium on the medicine, no consult fee, no monthly platform charge. The price you see is essentially the drug's own price, and the visit that gets you there costs nothing. Few platforms pair a brand-only menu with zero premium. TeleSlim Clinic is another brand-only route, run by obesity-medicine physicians who send prescriptions to your own pharmacy in six states.

Who should choose it, and who should skip it

Choose NowPatient if you want the branded drug, value a transparent fee structure, or specifically need the oral Wegovy tablet. It also suits people who plan to use insurance or a manufacturer savings card against a brand prescription, since you're holding a legitimate brand-name script rather than a compounded one. In California, JumpstartMD adds in-person visits and coaching, with 14 clinics plus online care and physicians who prescribe brand-name GLP-1s.

Skip it if budget is your top priority. Compounded semaglutide and tirzepatide from other providers usually land a fraction of the cost, and paying brand list price out of pocket is a heavy lift for most people. A few practical frictions matter too: NowPatient doesn't publish which states it serves (that's sorted during intake, not shown upfront), and every price is per pack, so working out a monthly cost is left to you.

Trust, safety, and medical oversight

On the safety ledger, NowPatient looks clean. There are no FDA warning letters against it, and because it dispenses only approved brand-name medication, there's no compounding pharmacy partner whose accreditation you'd need to scrutinize. The free-consultation model is clinician-gated: a prescriber has to write the script before you pay for anything. The main caveat is transparency around logistics: the published state list and any shipping terms are thin on the US side, so confirm coverage for your state and your total delivered cost during the free intake before you commit. You can see how we weigh these factors in our scoring methodology.

Bottom line

NowPatient is a clean, honest, brand-only GLP-1 provider for people who want the branded drug and a no-fee path to it, and it's one of the only places offering Wegovy as a pill. Go in clear-eyed on two things. You're paying full brand price: $215.98 for the cheapest injection pack, $251.98 for Mounjaro. And you're buying by the pack, not by the month, at the lowest dose in each range, so budget above those figures, not at them, and add the shipping and import duties line ($75 on pens, $20 on tablets) to each order. If that's the trade you want, NowPatient makes it about as straightforward and premium-free as brand-name GLP-1 access gets. If you'd rather save money with a compounded route, look elsewhere.

The Bottom Line

NowPatient scores highest on the strength of its clinical program: drug options and dosing support.

Score: 6.9/10Best for: Brand-name GLP-1 access without a compounded route

Ready to start with NowPatient?

See current pricing and start your free consultation.

Frequently Asked Questions

NowPatient offers only brand-name, FDA-approved medications and does not sell any compounded semaglutide or tirzepatide. Its weight-management catalog includes Mounjaro, Wegovy, Saxenda and Foundayo. If you specifically want the lower-cost compounded route, NowPatient is not the platform for it.
The consultation is free; you pay for the medication plus a shipping and import duties charge shown on each treatment page. Prices are listed per pack, and the lowest-strength packs are $99 for 30 Wegovy tablets, $113.85 for 30 Foundayo tablets, $215.98 for one Wegovy pen, $251.98 for one Mounjaro pen and $440.82 for five Saxenda pens. Higher strengths cost more, so confirm the price for your prescribed dose before ordering.
NowPatient's weight-management lineup includes Mounjaro (tirzepatide), Wegovy as an injection and as an oral tablet, Saxenda (liraglutide) and Foundayo (orforglipron) tablets. Offering Wegovy as both an injection and a pill is relatively uncommon among telehealth platforms. A clinician determines which, if any, is appropriate for you.
Yes. Per NowPatient, the consultation is completely free and you only pay for the medication if a clinician prescribes one. There is no obligation to buy, and you are not charged a separate visit fee. This makes it low-risk to see whether you qualify.
NowPatient is a US-UK telehealth platform headquartered in Austin, TX, but it does not publish a specific US state list; availability is determined during intake. Confirm your state qualifies before completing a consultation. Any shipping inclusions may differ between its US and UK operations.
NowPatient doesn't use public promo or coupon codes. Third-party sites advertising "NowPatient discount codes" are typically fake; any current offer applies automatically through the link on this page.
NowPatient is an operating telehealth provider, and we found no FDA warning letter on file for it. We could not confirm a LegitScript certification from its public pages. We last checked its prices and policies on its own site in November 2026. We scored it 6.9/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for NowPatient. The concerns our review flags: Prices are per pack and rise with strength, and each order adds a shipping and import duties charge; No compounded semaglutide or tirzepatide (usually the cheaper route); State availability determined during intake, not shown upfront. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this NowPatient review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See NowPatient's current pricing

Start your free consultation to check eligibility and today's price.